4//SEC Filing
Doyle Ramona 4
Accession 0001209191-22-002062
CIK 0001601830other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:48 PM ET
Size
9.8 KB
Accession
0001209191-22-002062
Insider Transaction Report
Form 4
Doyle Ramona
Chief Medical Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-01-03$2.47/sh+40,322$99,595→ 40,322 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-03−40,322→ 709,678 totalExercise: $2.47Exp: 2030-12-30→ Class A Common Stock (40,322 underlying)
Footnotes (2)
- [F1]Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person.
- [F2]Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001856069
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:48 PM ET
- Size
- 9.8 KB